Literature DB >> 27338731

Prediction of 5-year survival in advanced-stage ovarian cancer patients based on computed tomography peritoneal carcinomatosis index.

Daniel Diaz-Gil1, Florian J Fintelmann2, Sanaz Molaei2, Azadeh Elmi2, Sandeep S Hedgire2, Mukesh G Harisinghani2.   

Abstract

OBJECTIVE: To evaluate whether the quantification of peritoneal metastases in advanced-stage ovarian cancer patients using the peritoneal carcinomatosis index, detected by CT (CT-PCI), correlates with the serum levels of tumor marker CA-125 and 5-year survival.
METHODS: The CT-PCI was determined in 82 patients with stage III or stage IV ovarian cancer using the Sugarbaker classification prior to cytoreductive surgery. Linear regression analysis was used to correlate CT-PCI and CA-125 levels. Correlation of presurgical CT-PCI, optimal surgical cytoreduction, and 5-year survival was established using binary logistic regression analysis. A score for prediction of 5-year survival probability was established using multivariate backwards binary logistic regression.
RESULTS: Presurgical CT-PCI correlates significantly with presurgical CA-125 serum levels (r = 0.487, P < 0.001). Multivariate binary logistic regression suggested significantly improved 5-year survival with lower CT-PCI and lower ECOG performance scores.
CONCLUSION: CT-PCI allows quantification of peritoneal disease in advanced-stage ovarian cancer patients, similar to CA-125. CT-PCI in combination with ECOG performance has the potential to help evaluate the 5-year survival probability.

Entities:  

Keywords:  CA-125 antigen; Computed tomography; Neoadjuvant therapy; Ovarian cancer; Peritoneal disease; Prognosis

Mesh:

Substances:

Year:  2016        PMID: 27338731     DOI: 10.1007/s00261-016-0817-5

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  6 in total

1.  DLEU1 contributes to ovarian carcinoma tumourigenesis and development by interacting with miR-490-3p and altering CDK1 expression.

Authors:  Li-Li Wang; Kai-Xuan Sun; Dan-Dan Wu; Yin-Ling Xiu; Xi Chen; Shuo Chen; Zhi-Hong Zong; Xiu-Bo Sang; Yao Liu; Yang Zhao
Journal:  J Cell Mol Med       Date:  2017-06-09       Impact factor: 5.310

2.  Role of Galectin-3 Combined with Multi- Detector Contrast Enhanced Computed Tomography in Predicting Disease Recurrence in Patients with Ovarian Cancer

Authors:  Emanuela Anastasi; Silvia Gigli; Maria Santulli; Sara Tartaglione; Laura Ballesio; Maria Grazia Porpora; Teresa Granato; Carlo Catalano; Antonio Angeloni; Lucia Manganaro
Journal:  Asian Pac J Cancer Prev       Date:  2017-05-01

Review 3.  Clinical significance of plasma D-dimer in ovarian cancer: A meta-analysis.

Authors:  Jiacong Wu; Ziyi Fu; Guangquan Liu; Pengfei Xu; Juan Xu; Xuemei Jia
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

4.  LncSOX4 serves an oncogenic role in the tumorigenesis of epithelial ovarian cancer by promoting cell proliferation and inhibiting apoptosis.

Authors:  Yulan Liu; Yan Wang; Dongmei Yao; Diansheng Cui
Journal:  Mol Med Rep       Date:  2018-04-18       Impact factor: 2.952

5.  Prediction of candidate RNA signatures for recurrent ovarian cancer prognosis by the construction of an integrated competing endogenous RNA network.

Authors:  Xin Wang; Lei Han; Ling Zhou; Li Wang; Lan-Mei Zhang
Journal:  Oncol Rep       Date:  2018-09-13       Impact factor: 3.906

6.  Ovarian cancer subtypes and survival in relation to three comprehensive imaging parameters.

Authors:  Hanna Sartor; Maria Bjurberg; Mihaela Asp; Anna Kahn; Jenny Brändstedt; Päivi Kannisto; Karin Jirström
Journal:  J Ovarian Res       Date:  2020-03-07       Impact factor: 4.234

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.